The resistance investigation of the top 20 rice cultivars grown in Taiwan.
\r\n\tBasic science studies have provided new insights into the pathophysiology of β-thalassemia. Studies of genotypic and phenotypic heterogeneity among patients and a better understanding of the control of erythropoiesis have provided new targets for designing novel agents that can be tailored to individual patient needs. JAK-2 kinase inhibitors and agents targeting the GDF-11/SMAD pathway are in clinical trials.
\r\n\r\n\tThis book will attempt to discuss the historical background of the disease and present the most up-to-date material regarding disease management in today's world for the reader to be updated on the best practice management of the disease.
",isbn:"978-1-83969-158-4",printIsbn:"978-1-83969-157-7",pdfIsbn:"978-1-83969-159-1",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,hash:"23abb2fecebc48a2df8a954eb8378930",bookSignature:"Dr. Akshat Jain",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/10727.jpg",keywords:"History of Gene Mutation, Genetic Counselling, Anemia, Genotyping, Hemoglobin Electrophoresis, HLA typing, Hemolysis, Aplastic Anemia, Blood Transfusion, Laboratory Testing, Fetal Hemoglobin Modifiers, Gene Therapy",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"February 4th 2021",dateEndSecondStepPublish:"March 4th 2021",dateEndThirdStepPublish:"May 3rd 2021",dateEndFourthStepPublish:"July 22nd 2021",dateEndFifthStepPublish:"September 20th 2021",remainingDaysToSecondStep:"3 days",secondStepPassed:!0,currentStepOfPublishingProcess:3,editedByType:null,kuFlag:!1,biosketch:"A board-certified pediatrician with a specialization in pediatric hematology-oncology and stem cell transplantation. In collaboration with Harvard Medical School, he studied and reported the outcomes of a global hemophilia collaboration. He is a member of the American Board of Pediatrics, Hematology, and American Board of Pediatrics, also he is a Committee member for the American Society of Pediatric Hematology-Oncology Special Interest Group in Global Pediatric Hematology oncology.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"344600",title:"Dr.",name:"Akshat",middleName:null,surname:"Jain",slug:"akshat-jain",fullName:"Akshat Jain",profilePictureURL:"https://mts.intechopen.com/storage/users/344600/images/system/344600.jpg",biography:"Akshat Jain M.D. M.P.H.\n11175 Campus Street \nLoma Linda, California 92354\nPhone: (917) 331-3216\nakshatjainusa@gmail.com \n\nMEDICAL EDUCATION \n●\tS.S.R. Medical College, Belle Rive, Mauritius - MBBS, Bachelor of Medicine Bachelor of Surgery, 2007\n●\tPediatrics Residency Training ,The New York Medical College, Metropolitan Hospital , Dec2008-Dec 2011\n●\tPediatric Hematology Oncology and Stem Cell Transplant Fellowship, Cohen’s Children's Hospital of New York at LIJ-North Shore Health system. July 2012- September 2015\n●\tMaster’s in Public Health ,Hofstra University School of Public Health ,New York , August 2015\n\n\nHONORS/ AWARDS \n●\tThe New York Academy of Medicine Honorary Associate Award , December 2009\n●\tProgram Leadership Award - Committee of Interns and Residents (C.I.R./SIEU), April 2010\n●\tAmerican Academy of Pediatrics Program Delegate Award, New York Medical College, December 2010.\n●\tCitation of Honor from New York County for Excellence in Medicine and Service to Long Island, New York,Nassau county executive chambers , August 15,2015 \n●\tTimes of India N.R.I. ( Non Resident Achiever ) award , August 2015 \n●\tCertificate for academic excellence –Hofstra University School of Health Science & Human Services, New York August 26, 2015\n●\tAmerican Society of Hematology Leadership Institute Award , April 2016\n●\tGlobal Health Speaker Award , convener of Global Health Symposium, Hofstra NorthWell School of Medicine and School of Public health , May 2016\n●\tInternational Pediatric Lymphoma Meeting ,Session Chairperson of Pediatric Lymphoma , Indian Society of Hematology and Oncology , November 2016\n●\tContent Leader Award for Hematology perspective’s in the Global CoronaVirus Pandemic Preparedness Response for Medical Association of physicians of Indian Origin, April 2020.\n●\tConvener and Chairperson International Webinar for COVID 19 Coagulopathy, May 2020. \n●\tFeatured in the Top Doctors magazine 2020, ranked top pediatric Hematologist Oncologist for Southern California.\n\nNATIONAL/INTERNATIONAL POSITIONS \n●\tHofstra University Dean Advisory Board for the School of Health Professions, December 2017\n●\tEditorial Board – American Society of Pediatric Hematology Oncology Communications Committee, International Journal of Hematology Research (ISSN 2409-3548)\n●\tReviewer - JAMA Pediatrics (ISSN: 2168-6203), British Medical Journal (ISSN, 1468-5833), JAMA Oncology (ISSN: 2374-2437), International Journal of Hematology Research (ISSN 2394—806X), Journal of Pediatric Hematology and Oncology (ISSN: 1536-3678), New England Journal of Medicine (Resident 360). \n●\tMember – Core committee: American Cancer Society (A.C.S.) and American Academy of Pediatrics (A.A.P.) - Joint global pediatric Oncology taskforce.\n●\tAdvisor -World Health Organization, South East Asia for maternal and child health initiatives.( 2013-Ongoing) , Ministry of Health and Family Welfare ,Government of India ( 2014- Ongoing ) , American Academy of Pediatrics &American Cancer Society Global Taskforce on Pediatric Cancers.( 2014-Ongoing )\n●\tEditor – AAPI journal (American Association of Physicians of Indian Origin. Circulation -40,000)\n●\tVisiting Professorship in Hematology Oncology and Stem Cell Transplantation, Rajasthan University of Medical Sciences, India. ( 2009-Ongoing )\n●\tIndustry Advisor – Bayer, UniQure, Sanofi-Genzyme, Takeda, CSL Behring\n●\tDirector of International Bone Marrow Failure Consortium- India, part of the Global Hematology Initiative of Cohen Children’s Medical Center, New York, August 2015-2017. \n●\tCommittee member for the American Society of Pediatric Hematology Oncology Special Interest Group in Global Pediatric Hematology oncology. ( 2016- Ongoing)\n\n\n WORK EXPERIENCE \nNov 2017- Current Loma Linda University Children’s Hospital \n Director Division of Pediatric Hematology \n Director, Comprehensive Hemophilia Program\n Director, Comprehensive Sickle Cell Program \n Division of Pediatric Hematology Oncology and Stem Cell Transplantation\n Professor of Public Health, Loma Linda University School of Public Health \n\nMar 2017– Oct 2017 Pediatrics and Pediatric Hematology Oncology Practice \n Adventist Health Ukiah Valley, California \n\nSept 2015 –Aug 2016 Assistant Professor Pediatrics, Hofstra North Shore LIJ School of Medicine \n Section Head –Global Pediatric Hematology Oncology and Stem Cell Transplantation\n North Shore LIJ Health system.\n Associate Adjunct Faculty, Hofstra University School of Public Health.\n\nJuly 2012 – Sep 2015 The Steven and Alexandra Cohen’s Children's’ Hospital of New York at LIJ-North Shore \n Hofstra University - Pediatrics Hematology Oncology and Stem Cell Transplant Fellowship \n Chief - Jeffrey Lipton MD\n\nDec 2011- April 2012 Global Health : SMS Medical College and Group of Hospitals, Government of India \n Project Director for Project A.G.N.I. - Set up a regional Lead Poisoning prevention and \n anemia nodal center \n \n Course Director - Pediatric Subspecialty training module for Pediatricians at J.K. Lone \n Children’s Hospital for Government of India. \n\nDec 08- Dec 2011 The New York Medical College, Residency in Pediatrics \n Metropolitan Hospital, NY\n Maria Fareri Children's Hospital at Westchester.\n The Memorial Sloan Kettering Hospital. NY\n House staff on Stem Cell Transplantation service.\n \nApril – August 2008 Oklahoma State Medical Association (O.S.M.A.) Externship Program\n The Integris Baptist Teaching Hospital and Nazih Zuhdi Transplant Center\n\nRESEARCH EXPERIENCE \nNov 2017 – Ongoing: Current and ongoing – Director, Inherited Bleeding Disorder Experimental Therapeutics Program, Loma Linda University School of Medicine\nJan 2014 –July 2015 - Hofstra University School of Public Health \n Needs Assessment to barriers in cancer care for newly diagnosed patients in a resource \n Limited setting. \n Principal Investigator - Akshat Jain, Co-PI -Corrine Kyriacou \n\nJune 2012- July 2015 - Steven and Alexandra Cohen Children’s Medical Center \n Study – Non Invasive assessment of endothelial dysfunction in children with Sickle cell \n Disease. \n Co-Principal Investigator – Banu Aygun MD\n Study – Multicenter study assessing outcome of Reduced Intensity Conditioning for \n patients undergoing hematopoetic stem cell transplantation for Sickle cell disease . \n Co-Principal Investigator – Indira Sahdev MD\n \nJan 2012- Mar12 A.G.N.I. (Anterograde Growth Normalization Initiative) \n Project Director, Project of Government of India for establishment of Universal Lead \n Independent Pilot project to study effects of Elevated Blood Lead levels in children \n suffering from Developmental disorders- Adapted by W.H.O. 2014 for a National Level \n Lead Screening program, India \n \nJan 2009- Dec11 The New York Medical College, Metropolitan Hospital Center. NY\n Resident Physician – Hypothalamic volumes in patients with Growth Hormone deficiency.\n Maria Fareri Children's hospital / Dr.Richard Noto - Pediatric Endocrinology\n \nApril 2008-Dec 08 Nazih Zuhdi Transplant Institute, Integris Baptist Hospital, Oklahoma City\n Project – Single institution outcome study for Solid organ transplants\n Research Assistant Department of Hepatology\n \nOct 2007 – Dec07 Mount Sinai School of Medicine, New York, NY\n Project- Arterio-venous fistula post liver transplantation.\n Research mentor-Dr. Charissa Chang, Assistant Professor in Department of Liver Diseases. \n\nCERTIFICATION\n\n1.\tCalifornia State Medical License 8/2016- Present , New York State Licensure 8/2013-12/16\n2.\tAmerican Board of Pediatrics - Board certified, 11/14- Present\n3.\tAmerican Board of Pediatric Hematology Oncology – Board Certified , 06/2018- Present\n4.\tNeonatal Advanced Life Support 06/2009-Present \n5.\tPediatric Advanced Life Support 06/2009-Present \n6.\tECFMG Certification 12/2007-Present \n\nORAL PRESENTATIONS \n\n\n1.\tLeukemia and Lymphoma Society of America C.M.E. Symposium presentation – Leukemia and Beyond: Advances in Cancer Care and Blood Disorders in the 21st Century, October 2019\n2.\tLoma Linda University School of Medicine – Grand Rounds, Advances in the Management of Sickle Cell Disease, March 2019.\n3.\tLoma Linda University School of Medicine – Experimental Therapeutics in Sickle Cell Disease – New Horizons at Loma Linda , November 2018 .\n4.\tAdventist Health Ukiah , California - Neurological Defects of Iron Deficiency and Lead Poisoning in Humans , October 2017\n5.\tHofstra NorthWell School of Medicine - National Public Health Symposium on Global Public Health , Convener and Moderator ,April 2016 \n6.\tCleveland Clinic Children’s Medical Center, Ohio – Non BCR-ABL Myeloproliferative syndromes of childhood, January 19, 2016.\n7.\tChildren’s Hospital at SMS Medical College ,India – Pediatric Hematology Oncology Emergencies for the Tropics, November 13, 2015 \n8.\tHarvard Medical School, Boston Children’s Hospital Division of Pediatric Hematology – Advances in Global Hematology, Annual Hemophilia Twining symposium, August 2, 2015.\n9.\tNew York Medical College as Grand Rounds, Division of Pediatrics – Emergencies in Pediatric Hematology and Oncology, April 2015.\n10.\tMaurice A. Deane School of Law, Hofstra University, New York - Healthcare Access to Undocumented immigrants: Immigration reform and its impact, March 2015.\n11.\tPediatric Academic Society/Society of Pediatric Research (PAS/SPR) as platform presentation, Vancouver, BC - Global Child Health in Rich & Poor Countries Lessons Learned from Indigenous Health, May 3 2014.\n12.\tDepartment of Medicine and Medical Oncology, as Guest International faculty , SMS Medical College, India - Advances in Stem Cell Transplantation – January 2014.\n13.\tInternational health conference, Global Association of physicians of Indian Origin , New Jersey – Impact of Lead Intoxication in Low to middle income countries , August 2012.\n14.\t139st APHA Annual Meeting and Exposition 2011, Boston - Use of decision support in a Harlem pediatric emergency department to increase prescription of controller medicines to patients with poorly controlled asthma - Wilson Wang, Carolina Valez, Nicole Falanga, Vikas Bhambhani , Akshat Jain , Farhad Gazi, David Spiller, Paper no-227188 , November 2011 \n15.\tThe New York Academy of Medicine, Resident award night - False negative result in newborn screening for Congenital Adrenal hyperplasia - July 2009.",institutionString:"Loma Linda University Children's Hospital",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Loma Linda University Children's Hospital",institutionURL:null,country:{name:"United States of America"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"16",title:"Medicine",slug:"medicine"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"280415",firstName:"Josip",lastName:"Knapic",middleName:null,title:"Mr.",imageUrl:"https://mts.intechopen.com/storage/users/280415/images/8050_n.jpg",email:"josip@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copy-editing and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6550",title:"Cohort Studies in Health Sciences",subtitle:null,isOpenForSubmission:!1,hash:"01df5aba4fff1a84b37a2fdafa809660",slug:"cohort-studies-in-health-sciences",bookSignature:"R. Mauricio Barría",coverURL:"https://cdn.intechopen.com/books/images_new/6550.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4816",title:"Face Recognition",subtitle:null,isOpenForSubmission:!1,hash:"146063b5359146b7718ea86bad47c8eb",slug:"face_recognition",bookSignature:"Kresimir Delac and Mislav Grgic",coverURL:"https://cdn.intechopen.com/books/images_new/4816.jpg",editedByType:"Edited by",editors:[{id:"528",title:"Dr.",name:"Kresimir",surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"54205",title:"The Application of Genomic Approaches in Studying a Bacterial Blight-Resistant Mutant in Rice",doi:"10.5772/67331",slug:"the-application-of-genomic-approaches-in-studying-a-bacterial-blight-resistant-mutant-in-rice",body:'\nRice is a staple food crop and provides more than one-fifth of the calories to humans [1]. However, rice production is often challenged by bacterial blight disease (BBD), which is one of the most destructive diseases caused by Xanthomonas oryzae pv. oryzae (Xoo). This disease was first found in rice by Japanese farmers in 1884. It was not a serious problem in rice production until the release of high-yielding varieties during the 1960s–1970s [2–4]. Some field observations displayed that this disease can lead up to 50% losses in rice planting areas [3, 5]. In Taiwan, BBD often occurs in the second crop season, and its annual pathogenesis area is usually more than 20,000 hectares, accounting for about 4% of the total rice production area. Because of climate change, this disease has become more and more serious recently [6, 7]. Furthermore, International Rice Research Institute (IRRI) proposed that BBD can cause up to 70% of yield loss when susceptible varieties are grown in the environments suitable for Xoo pathogens (http://www.knowledgebank.irri.org/index.php?option=com_zoo&task=item& item id=806&Itemid=606).
\nThe existing prevention of BBD includes field management, fertilizer control, pesticide application and resistance varieties with the major resistance gene (R gene) or the pattern recognition receptor gene (PRR gene). In field management, appropriate spacing could prevent rice plants from the infection of pathogens. Appropriate nitrogen fertilizer application could prevent rice plants from pathogens’ infection [8]. The spray of probenazole or other chemicals might prevent the infection before transplantation, but this treatment could not be applied in tropical regions [8–10]. So far, the use of resistant varieties is considered to be the most effective strategy against this disease. In recent years, there is no specific bactericide which could effectively control BBD, and chemicals application also increases production cost, plant injury and environmental pollution. On the other hand, the evolution of pathogens increases the diversity and the difficulty in the breeding program for durable or broad-spectrum resistance [11–13]. Therefore, breeding the bacterial blight-resistant varieties is urgently required to meet the demand of a safe rice production.
\nPrevious studies demonstrated that climate change has been proposed to affect the microflora of Xoo in the field and even change the life cycle and evolution of Xoo pathogen. Large-scale and long-term cultivation of Xa4-mediated resistant varieties also altered the Xoo population. Consequently, resistant varieties carried with only Xa4 have become susceptible to Xoo in Southeast and South Asia [14]. Bacterial blight is one of the serious diseases often occurring in the second crop season (August to November) in Taiwan. Our previous results also displayed that the top 20 cultivars with large-scale cultivation in Taiwan were susceptible to Xoo (Table 1). Therefore, if the bacterial blight disease is endemic, it will cause serious loss to the rice production. These results indicated again that breeding of the bacterial blight-resistant varieties is urgently required to meet the demand of the Taiwanese rice industry.
Planting area during 2010–2015 | Variety | Response for Xoo | ||
---|---|---|---|---|
Order | Ha | XM42 | XF89-b | |
1 | 484,063 | Tai Nan No. 11 | 7 | 7 |
2 | 142,132 | Taikeng No. 8 | 7 | 7 |
3 | 119,641 | Taikeng No. 14 | 7 | 9 |
4 | 98,404 | Taikeng No. 16 | 7 | 9 |
5 | 47,139 | Taikeng No. 9 | 9 | 9 |
6 | 46,204 | Taichung-Hsien No. 10 | 9 | 9 |
7 | 41,424 | Taikeng No. 2 | 7 | 9 |
8 | 39,374 | Kaohsiung 139 | 9 | 9 |
9 | 39,149 | Taikeng No. 11 | 9 | 7 |
10 | 23,767 | Taichung-Hsien No. 1 | 7 | 9 |
11 | 22,965 | Taichung 192 | 9 | 7 |
12 | 19,357 | Taikeng No. 4 | 7 | 7 |
13 | 19,108 | Tail Nung No. 71 | 5 | 7 |
14 | 13,989 | Tail Nung No. 67 | 9 | 9 |
15 | 13,867 | Taikeng No. 5 | 7 | 9 |
16 | 9341 | Tai Tung No. 30 | 9 | 7 |
17 | 9178 | Kaohsiung 145 | 7 | 7 |
18 | 7318 | Taoyuan No. 1 | 5 | 7 |
19 | 7152 | Taikeng-No. 1 | 7 | 7 |
20 | 5660 | Taichung-Hsien No. 17 | 9 | 9 |
The resistance investigation of the top 20 rice cultivars grown in Taiwan.
Note: The resistance of the top 20 rice cultivars was investigated according to the Kauffman’s method [66]. The lesion level can be classified by a scale of five scores, such as 1 (HR), 3 (MR), 5, 7 (MS) and 9 (HS).
The availability of resistant sources is the major limitation in breeding. A series of near isogenic lines (NILs) harboured various Xa genes (IRBB NILs) that were developed on the susceptible cultivar, IR24, at the International Rice Research Institute (IRRI) [15]. The IRBB lines, often applied in the domestic resistance breeding, were introduced and inoculated with Taiwan local pathogens to test their responses in our previous work. The results indicated that only the IRBB lines carried Xa5 or Xa7 showed moderate resistance while all other IRBB lines carried single Xa gene showed susceptibility to the local pathogens (Figure 1) [16]. Many of the resistance genes were introduced into the susceptible varieties by marker-assisted selection (MAS) to improve bacterial blight resistance [17, 18]. However, many of these genes lose their resistance due to the fast evolution of pathogen [19]. It has been reported that durable or broad-spectrum resistance can prolong the bacterial blight resistance in rice [20, 21]. Actually, broad-spectrum and durable resistance can be accomplished by the introduction of one very resistance gene and pyramiding with two to three other resistance genes [22]. However, large-scale and long-term cultivation of resistant varieties might result in changes of pathogen race in the Xoo population and cause the breakdown of resistance [14, 23]. These findings indicate that exploration of new germplasms with novel resistance genes become a crucial subject in breeding resistance variety.
The resistance investigation of IRBB lines against the local pathogens in Taiwan [16].
Sodium azide (NaN3, SA) induced mutants can be applied to any rice breeding program at any facility, while genetically modified mutants can only be handled in the isolating facilities under the governmental regulation. A TNG67 mutant pool was developed by SA mutagenesis at the Taiwan Agricultural Research Institute (TARI) in our previous breeding program. All the mutants were screened and purified according to their morphological traits by at least 10 generations of self-crossing, selection and purification following pedigree procedures. Over 3000 pure line mutants on the same genetic background of TNG67 variety were maintained in the pool [24]. The genetic diversity of mutant lines in this pool includes disease resistance (blast, bacterial blight and sheath blight) [25], pest resistance (brown planthopper, white backed planthopper and leafroller) [26], herbicide resistance (bentazon, glufosinate and glyphosate) [27] and many agronomic traits; grain quality and morphology diversities seldom found in rice cultivars. These results suggested that the TNG67 mutant pool should have high potential in basic research as well as variety improvement [24].
\nTo improve the bacterial blight resistance for local rice varieties, we attempted to obtain the local resistant germplasms from the selection of TNG67 mutant pool [7]. So far, at least 50 bacterial blight-resistant mutants have been selected from the mutant pool (Figure 2). These mutants might carry various genotypes of resistance and participate in the resistant pathway. Among them, SA0423 and SA0424 showed stable resistances against various Xoo pathogens for many years. The genetic analysis displayed that these two mutants might carry multiple resistant genes to confer broad-spectrum resistance and show different resistant phenotypes (data shown in the following section).
The screening of resistance mutants from TNG67 mutation pool by inoculation of local pathogens in Taiwan.
At present, planting resistant varieties is accepted as the most efficient, reliable and economic strategy against bacterial blight. It has been proposed that the durable and broad spectrum resistance of plants was usually governed by multiple genes or quantitative trait loci (QTLs) [28]. Therefore, the discovery of novel resistance genes against Xoo is very important in the breeding program for disease resistance. So far, 42 resistance loci (Xa) for BBD have been identified and characterized [refer to: http://www.nig.ac.jp/labs/PlantGen/english/oryzabase-e/; http://www.gramene.org/; http://www. ricedata.cn/and previous reviews] [29–31]. Most of these genes were found to be controlled by dominance [32], but 14 of them, such as xa5, xa8, xa13, xa15, xa19, xa20, xa24, xa25, xa26b, xa28, xa31, xa32, xa33 and xa34, were found to be regulated in a recessive manner [33, 34]. These genes distribute among 9 chromosomes of rice genome, and 16 of them are clustered on chromosome 4 (Xa1, Xa2, Xa14, Xa31(t) and Xa38) and chromosome 11 (Xa3/26, Xa4, Xa10, Xa21, Xa22, Xa23, Xa30(t), xa32(t), Xa35(t), Xa36(t) and Xa40), respectively. At present, Xa1, Xa3/Xa26, xa5, Xa10, xa13, Xa21, Xa23, Xa25, Xa27 and Xa40 have been cloned and characterized to encode six types of proteins, i.e. NBS-LRR, receptor kinase like protein, ER membrane protein, Os8N3 protein, MtN3/saliva family member and WAK3, indicating the existence of multiple mechanisms of bacterial blight resistance in rice [35–47].
\nNear isogenic lines (NILs) with various Xa genes on the background of IR24, a very susceptible cultivar, named IRBB NILs were applied as the donor parents [15]. Besides, molecular markers linked with Xa genes in IRBB NILs were developed through comparative mapping strategy for improving the BBD resistance of commercial cultivars [17, 18]. However, it has been reported that the plant resistance genes may breakdown due to the fast evolution of pathogen isolates [19]. Many studies suggested that large-scale and long-term cultivation of resistant varieties may result in changes of pathogen race in Xoo population and caused the breakdown of resistance [14, 23]. These findings indicated that exploration of new resistance genes has become an important subject for breeding resistance variety.
\nAmong the previously selected resistant mutants, SA0423 shows a stable resistance to Taiwan local pathogens for years. Hence, their genetic properties and BBD resistance genes were characterized in our team. Except for the bacterial blight resistance, SA0423 also has thinner leaf blades, shorter plants, more erect plant type and less tiller number than its mutagenesis parent, TNG67 (Figure 3). A strong and stable Taiwanese epidemic pathogen, Xoo XF89b, has been used for genetic analysis and mapping the bacterial blight-resistance genes. Taichung Native 1 (TN1), a very susceptible indica rice cultivar, was used as the recipient parent. The cross TN1/SA0423 was made to generate F1 and F2 materials for genetic analysis and mapping of resistant genes. After pathogen infection, the lesion lengths of TN1, SA0423 and TN1/SA0423 F1 were 17.2 ± 1.1, 1.2 ± 0.7 and 3.4 ± 0.9 cm, respectively, indicating that the BBD resistance of SA0423 is partial dominance (Figure 4). The lesion lengths of the TN1/SA0423 F2 population showed a continuous distribution (Figure 5) and indicated that the disease resistance of SA0423 is controlled by multiple genes or quantitative trait loci (QTLs).
Morphology of TNG67, SA0423 and their disease responses at 28 days after inoculation (DAI) with Taiwanese Xanthomonas oryzae pv. oryzae XF89b.
Morphology of TN1, SA0423 and their F1 individual, and the disease response at 28 days after inoculation (DAI) against Taiwanese Xanthomonas oryzae pv. oryzae XF89b (A, upper panel). The lower panel of (B) shows the morphology of leaf lesion at 28 DAI; left panel shows the leaf lesion (cm) investigated at 28 DAI. Error bar is the standard error of mean (n = 3). Means with the same letter are not significantly different at 5% level by LSD test.
Distribution of lesion length (cm) after inoculation with Taiwanese Xanthomonas oryzae pv. oryzae XF89b in an F2 population from the cross, TN1/SA0423.
A linkage map covering 12 chromosomes with an average distance of 11.2 cM was constructed and applied to map the resistance of SA0423 using 361 TN1/SA0423 F2 individuals [48]. QTL analysis was performed using the R program language platform (version 3.1.0; http://www.r-progect.org/) with an add-on package, qtl [46, 47]. Three QTLs are detected on chromosomes 11, 8 and 6 and account for 21.1, 11 and 9.6% of the observed phenotypic variance, respectively (Table 2 and Figure 6). Three QTLs are localized to 6, 7 and 14 cM intervals, respectively; they contribute to approximately 47% of the total phenotypic variation (resistance) and no epistatic effect could be detected among them [48].
QTL | Chr. | QTL (Confidence interval) (cM) | LOD | Phenotyping variance (%) | Additive effect | Dominance effect |
---|---|---|---|---|---|---|
qBBR11.1 (Q1) | 11 | 124 (121–127) | 26.60 | 21.10 | –1.64 | –0.44 |
qBBR08.1 (Q2) | 8 | 39 (34–41) | 15.04 | 11.04 | –1.20 | –0.82 |
qBBR06.1 (Q3) | 6 | 120 (111–125) | 13.20 | 9.58 | –1.13 | 0.79 |
The linkage mapping of SSR/InDEL markers and SA0423 resistance QTLs in the F2 population of TN1/SA0423. The markers and genetic distances (cM) are labelled to the right and left of the chromosome, respectively. The QTLs are coloured with red, and other published genes and QTLs associated with BBR are labelled as blue dots and lines, respectively.
According to QTL analysis, all the three identified QTLs contribute to 47% of the resistance indicating that other resistance genes may exist in SA0423 [48]. Therefore, the transcriptomes of TNG67 and SA0423 were determined by microarray technologies to explore the bacterial-resistant genes in SA0423.
\nFor a precise and non-destructive investigation in the infection process of bacterial blight pathogen after inoculation, a Xanthomonas fluorescent expression plasmid, pRBBZsGFP, was constructed with a strong fluorescent gene ZsGFP and the pBBR1MCS vector for simultaneous detection of bacterial blight pathogen infection and the gene expression [49]. Pathogens infection with XF89bZsGFP was conducted on the dark-treated albino seedlings of TNG67 rice variety; the multiplication and colonization of XF89bZsGFP could be detected in 0.5 hour after inoculation, and the maximum fluorescence was observed on the same leaf in 1 hour after inoculation (Figure 7). However, the fluorescence was reduced in the following time course indicating that the multiplication and colonization of XF89bZsGFP might be suppressed by the endogenous immune system of rice. At 7 DAI (days after inoculation), the stronger fluorescence was observed again on the same leaf and extended continuously to the leaf base, suggesting that the rice immune system was broken down by the XF89bZsGFP.
Visualization of X. oryzae pv. oryzae and E. coli expressing GFP in the dark-treated albino TNG67 seedlings.
After the infection of Xoo XF89b, RNA samples prepared from the leaves of TNG67 and SA0423 collected at 0, 0.5, 1, 2 and 6 hours, respectively, were applied in the transcriptomic analysis with Agilent Oligo Microarray (60K, custom-made, Agilent Technologies) [50]. The results demonstrated that 2727, 3585 and 18,432 differentially displayed transcripts were identified in SA0423, TNG67 and in both, respectively. Among them, 58 genes involved in SA0423 resistance were further conducted by bioinformatics strategies [refer to: http://www.nig.ac.jp/labs/PlantGen/english/oryzabase-e/; http://www.gramene.org/; http://www.ricedata.cn/and previous reviews] [29–31] as well as “plant-pathogen interaction” pathway (http://www.genome.jp/kegg), and clustered with BioLayout Express3D [51]. By confirming with real-time RT-PCR, 17 resistance gene candidates (Table 3) were selected for bioinformatics analysis, they have been proposed to be involved in plant-pathogen interaction pathway, biosynthetic pathway of plant hormones, autophagy and signal transduction prior to the induction of plant immune system [52].
Gene name | Gene ontology | |
---|---|---|
Ankyrin Ankyrin repeat-rich protein | BP | Cellular process, biosynthetic process, protein modification process, post-embryonic development, anatomical structure morphogenesis, response to endogenous stimulus |
MF | Binding, protein binding, catalytic activity, | |
ATG1 ATG1 | BP | Cellular process, cellular component organization, protein modification process |
CC | Plasma membrane | |
MF | Molecular function | |
CaM_Chr.1-1 OsCam1-3-Calmodulin | BP | Biological process, response to abiotic stimulus, post-embryonic development, signal transduction |
MF | Binding, protein binding | |
CaM Chr.1-2 OsCam3-Calmodulin | BP | Biological process, response to abiotic stimulus, post-embryonic development, signal transduction |
MF | Binding, protein binding | |
CaM_Chr.2 EF hand family protein | BP | Protein modification process, biosynthetic process |
CC | Cytoplasm | |
MF | Binding | |
CaM_Chr.5 OsCam2-Calmodulin | BP | Signal transduction |
CC | Plasma membrane | |
MF | Signal transducer activity, binding, protein binding | |
CMPG Immediate-early fungal elicitor protein CMPG1 | BP | Protein modification process, biological process |
CC | Intracellular | |
MF | Catalytic activity, binding | |
DUF26 Domain of Unknown function 26-lc | BP | Protein modification process, cellular process, metabolic process |
CC | Plasma membrane | |
MF | kinase activity, protein binding, cellular process, | |
FMO Flavin-containing monooxygenase family protein | BP | Cell death, signal transduction, metabolic process, response to biotic stimulus, cellular process, response to stress |
CC | Endoplasmic reticulum, membrane, cell | |
MF | Nucleotide binding, catalytic activity, binding | |
JOM Jasmonate O-methyltransferase | BP | Multicellular organismal development, cellular process, metabolic process |
CC | Cellular component | |
MF | Binding, protein binding, transferase activity | |
PxMP Peroxisomal membrane protein | BP | Biological process |
CC | Peroxisome, membrane | |
MF | Molecular function | |
SAM SAM dependent carboxyl methyltransferase | BP | Biological process, cellular process, metabolic process |
CC | Cellular component | |
MF | Transferase activity | |
SNARE SNARE associated Golgi protein | CC | Cytosol |
Ubi Ubiquitin family protein | MF | Molecular function |
Xa2 OsSAUR21—Auxin-responsive SAUR gene family member | BP | Response to endogenous stimulus |
MF | Molecular function | |
Xa25 Nodulin MtN3 family protein | BP | Biological process, cellular process, transport |
CC | Plasma membrane, membrane, cell | |
MF | Transporter activity | |
xa5 Transcription initiation factor IIA gamma chain | BP | Biosynthetic process, nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
CC | Nucleoplasm |
The resistance gene candidates identified from transcriptomic analysis in a bacterial blight-resistant mutant, SA0423.
Note: BP, biological process; CC, cellular component; MF, molecular function.
To confirm the function of the identified genes from transcriptomic analysis, the SSR markers flanking in 5 cM region of these genes were retrieved from GRAME web site, screened for the polymorphic markers between TN1 (the susceptible parent) and SA0423 (the resistant parent), and then genotyping was performed in the F2 population [53]. Simultaneously, the disease lesion of F2 individuals was investigated to represent the resistance phenotype after the inoculation of Xoo XF89b. The linkage between genotype and phenotype was conducted using R/qtl software by the single marker regression model. The results displayed that only RM6838 adjacent to Ankyrin showed a significantly high LOD (6.86) (Table 4) indicting that Ankyrin (LOC_Os08g15840) has a high potential to be involved in the resistance of SA0423. The bioinformatics analysis shows that this Ankyrin protein shares 76% similarity with the Arabidopsis RING type ligase, XBAT32, of an XB3 family. In Arabidopsis, Ankyrin has been proposed to negatively regulate 1-aminocyclopropane-1-carboxylate synthase (ACS), a key enzyme involved in the ethylene biosynthesis pathway, and then compromised immune system [54]. The real-time RT-PCR displayed that the expression level of Ankyrin in SA0423 was lower than that of TNG67, and higher expression levels of OsACS1 and OsACS3 were found in the BBD resistance mutant, SA0423 (Figure 8). These findings showed that ethylene metabolism may involve in the disease resistance of SA0423. A total of 15 mutations in the coding region resulting two mutation residues, Ser280Pro and Thr381Ala, were discovered in the Ankyrin of SA0423 through cloning and sequencing (data not shown). At the same time, the transgenic rice plants with less expression of ankyrin showed a significant resistance against Xoo XF89b isolate. Therefore, Ankyrin is considered to be one of the expression quantitative trait loci (eQTLs) involved in the bacterial blight resistance of SA0423.
Gene | Chromosome | Position (cM) | Marker | LODz |
---|---|---|---|---|
CaM_Chr.1-1 | 1 | 50.8 | RM6039 | 0.8941 |
CaM Chr.1-2 | 1 | 50.9 | RM572 | 1.7618 |
CaM_Chr.2 | 2 | 25.3 | RM6378 | 0.0886 |
CMPG | 2 | 131 | RM13938 | 0.5618 |
Xa2 | 4 | 107.4 | RM17492 | 1.2685 |
JOM | 4 | 120.3 | RM17604 | 0.5006 |
xa5 | 5 | 3 | RM17741 | 0.2725 |
CaM_Chr.5 | 5 | 104.7 | RM6972 | 0.5717 |
FMO | 6 | 19.1 | RM19556 | 0.2034 |
SAM | 6 | 33.5 | RM276 | 0.1920 |
DUF26 | 7 | 73.2 | RM3826 | 0.1547 |
SNARE | 7 | 116.1 | RM1362a | 0.2325 |
Ankyrin | 8 | 42.9 | RM6838 | 6.8579 |
ATG | 10 | 73.7 | RM5471a | 0.0479 |
Ubi | 10 | 99.8 | RM147 | 0.2880 |
Xa25 | 12 | 57.9 | RM28157 | 0.4657 |
PxMP | 12 | 69.6 | RM519 | 0.2940 |
Linkage analysis between the resistance gene candidates and the resistance trait of SA0423 by R/qtl.
Note: z LOD, log10 of odds.
Quantitative analysis of mRNA expression of Ankyrin and OsACS homologs in TNG67 and SA0423 after inoculated with Xoo XF89b by using real-time RT-PCR.
Proteomics technology provides a direct investigation of proteins which may participate in rice disease resistance. In previous studies, plasma membrane (PM) proteomic analysis of the genetically modified rice suspension cells with Xa21 demonstrated that PM-associated ATPase, phosphatase, hypersensitive-induced response protein, prohibitin, zinc finger/C2 domain protein, universal stress protein and heat shock protein might be involved in the early immune response against compatible and incompatible Xoos [55]. A proteomic analysis of Java 14 seedling revealed that 20 differentially displayed proteins were responded to bacterial inoculation and categorized into energy, metabolism and defence pathways [56]. These proteomic studies were conducted at 0, 12, 24 even 72 hours after inoculation [55, 56] whereas considering the rapidity of defence observed in other plant-pathogen interactions [57] and the short life cycle of Xoo, it is expected that Xoo might induce rice reprogramming immediately after pathogen infection.
\nA comparative proteomics analysis was conducted to characterize the proteomic profiling in leaves of TN1 (as a susceptible control), TNG67 and SA0423 after the infection of Xoo XF89b at 0, 6, 48 and 72 hours after pathogen inoculation (Figure 9). There were 60, 38 and 96 differentially displayed protein spots identified only in SA0423, TNG67 and TN1, respectively, by the separation of two-dimensional gel electrophoresis (2-DE). Finally, a total of 150 disease resistance-related proteins were identified from these protein spots through the ESI-Q-TOF mass spectrometry (MS) analyses. Ten resistance protein candidates (Table 5) were then determined by bioinformatics approach including annotation of metabolic pathway, comparative mapping analysis with published resistance loci [refer to: http://www.nig.ac.jp/labs/PlantGen/english/oryzabase-e/; http://www.gramene.org/; http://www.ricedata.cn/and previous reviews] [29–31] as well as ‘plant-pathogen interaction’ pathway (http://www.genome.jp/kegg), and clustered with BioLayout Express3D [51]. These candidates were proposed to be involved in ascorbate, glyoxylate and glutathione, and oxidative phosphorylation metabolisms.
Gene | Marker | hmzA | hmzB | htz | n | m(hmzA) | m(hmzB) | m(htz) | R2 | A | D | |D/A| | F | p | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L-ascorbate peroxidase 1, cytosolic (APX1) | RM7197 | 30 | 35 | 29 | 94 | 6.56 | 8.28 | 7.57 | 0.05 | 0.862 | 0.15158 | 0.18 | 2.5 | 0.08795 | |
Putative 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (BIPM) | RM5970 | 16 | 28 | 50 | 94 | 8.29 | 8.841 | 6.52 | 0.12 | 0.276 | –2.04831 | 7.41 | 6.05 | 0.00337 | * * |
Glyceraldehyde-3-phosphate dehydrogenase, putative, expressed (G3PD) | RM14336 | 23 | 23 | 40 | 86 | 6.75 | 7.833 | 7.4 | 0.02 | 0.539 | 0.10949 | 0.2 | 0.77 | 0.46538 | |
Aspartate aminotransferase (AST) | RM14099 | 42 | 22 | 14 | 78 | 6.61 | 9.433 | 7.29 | 0.14 | 1.412 | –0.73185 | 0.52 | 6.34 | 0.00281 | ** |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase, putative, expressed (BIPME) | RM8084 | 24 | 52 | 18 | 94 | 6.74 | 8.134 | 6.73 | 0.05 | 0.695 | –0.70982 | 1.02 | 2.34 | 0.10172 | |
Triosephosphate isomerase (TRI) | RM24714 | 16 | 33 | 45 | 94 | 7.43 | 8.23 | 7.01 | 0.03 | 0.401 | –0.81535 | 2.03 | 1.44 | 0.24307 | |
30S ribosomal protein S4, chloroplastic (RP30S) | RM5579a | 18 | 36 | 40 | 94 | 6.59 | 8.479 | 7.05 | 0.06 | 0.943 | –0.48336 | 0.51 | 3 | 0.05439 | |
Fructose-bisphosphate aldolase, chloroplastic (FBPA) | RM26143 | 10 | 46 | 35 | 91 | 8.09 | 7.596 | 7.31 | 0.01 | –0.247 | –0.53336 | 2.16 | 0.24 | 0.78348 | |
Cysteine synthase (CYS1) | RM520 | 23 | 28 | 43 | 94 | 7.8 | 6.835 | 7.8 | 0.02 | –0.483 | 0.47717 | 0.99 | 0.91 | 0.40443 |
Linkage analysis between the resistance protein candidates and the resistance trait of SA0423 by MapDisto. The “**” was indicated “statistical significance” (p ≤ 0.05).
2-DE image analysis of rice leaf proteome under Xoo XF89b infection. Total leaf proteins were extracted and separated by 2-DE then stained with sliver staining according to the previous protocol [58, 59]. An equal amount (200 μg) of the total proteins was loaded on each gel strip. The differentially expressed resistance-related proteins in TN1, TNG67 and SA0423 are marked as N, T and S, respectively.
The candidate genes identified from proteomics approach were genetically confirmed as previously described, the SSR markers flanking in 5 cM region of them were retrieved from GRAMENE web site, and screened for polymorphism TN1 (the susceptible parent) and SA0423 (the resistant parent). Genotyping analysis was performed in 94 TN1/SA0423 F2 individuals using the polymorphic markers. The lesion of these F2 individuals was investigated after the inoculation of Xanthomonas oryzae pv. oryzae XF89b as the resistance phenotype. The linkage between genotyping and resistance was analysed by MapDisto according to Lorieux’s protocol [60]. The result displayed that only RM5970 adjacent to the putative 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (BIPM) and RM14099 adjacent to aspartate aminotransferase (AST) showed significant association with the SA0423 resistance (Table 5). BIPM has been proposed to have some important roles in glycolysis, stomatal movement, vegetative growth and pollen production in Arabidopsis [61], but it was usually found to be differentially expressed under abiotic or biotic stress [62–64]. AST was found to be up-regulated in rice spotted leaf 5 (spl5) mutant that showed spontaneous HR-like lesions on its leaves, and a broadly enhanced resistance against rice blast and bacterial blight pathogens [65]. Based on these findings, BIPM and AST are found to have high potential to participate in the resistance mechanism of SA0423. These results provide novel insights into the molecular mechanisms of rice response to Xoo infection and discovery of new resistance genes as the basis for application in molecular breeding. Therefore, both BIPM and AST are considered to be the proteomic quantitative trait loci (pQTLs) for the bacterial blight resistance in SA0423.
Breeding resistance variety is the best strategy to overcome the bacterial blight disease damage in rice and is a very challengeable work. Availability of resistant genotype is the major limitation to the resistance improvement. However, plant disease resistance is a complex trait usually regulated by QTLs, epistatic effect, and influenced by the interactions among pathogen, host and environment.
\nIn this review, a durable resistance mutant, SA0423, was firstly obtained from screening a sodium azide-induced mutation pool on the genetic background of TNG67 rice variety. The genomic approaches and technologies were conducted according to the concept and flow of Central Dogma. In the genomic study, the inheritance and gene corresponding to the BBD resistance of SA0423 was conducted. Linkage maps were constructed, and three QTLs (qBBR06.1, qBBR08.1 and qBBR11.1) for resistance were identified from SA0423. Meanwhile, the linkage markers for each QTL were developed according to the linkage map for marker-assisted breeding.
\nThe transcriptomics and proteomics technologies were applied to identify the expressed genes and proteins corresponding to the pathogen inoculation for BBD resistance on SA0423. The differential displayed genes (or proteins) were annotated by blast with the gene database (NCBI and GRAMENE websites), and then their putative biological functions or the participating pathways were predicted by GO analysis. Besides, they were compared with the published resistance genes in Xa locus or putative rice ‘plant-pathogen interaction’ pathway to confirm the resistance genes or pathway in SA0423. The results demonstrated that 17 candidate genes (eQTLs) and 10 candidate proteins (pQTLs) might be involved in SA0423 resistance mechanism. The association between these candidates and SA0423 resistance was further evaluated by integration of genotyping and phenotyping of TN1/SA0423 F2 progeny through genetic approach. Both genomic and bioinformatics approaches were integrated to confirm the function and genetic relationship of the candidate genes with BBD resistance. The final results suggested that only one major expression QTLs (eQTLs) [53] and two protein QTLs (pQTLs) (Lin et al., 2017, paper in preparation ) are confirmed to confer the resistance of SA0423. It is worth to note that both the eQTLs and pQTLs identified in this study are not identified in the genetic mapping approach, and the products of eQTLs were not found in the protein profiling (pQTLs), and vice versa. These results showed that the genomic approach alone cannot unravel all the genes involved in the disease resistance of SA0423.
\nPhenomics or phenotype can provide the solid evidence for gene function. Our previous findings were tested through transgenic approach as well as marker-assisted backcrossing (MABC). The transgenic rice plants with less expression of ankyrin and BIPM showed significant resistance against Xoo XF89b isolate, supporting that these two eQTLs are involved in BBD resistance in rice. The identified resistance QTL, qBBR11.1, of SA0423 was introduced and improved the BBD resistance in a very susceptible indica variety, TCS10, through MABC approach. These results demonstrated that the QTLs identified from genomic, transcriptomic and proteomic approaches can be practically applied to improve the BBD resistance in rice breeding program.
The ketogenic diet is a mixed diet containing low carbohydrates, consisting primarily of proteins and fat [1, 2]. Some healthy foods are eaten on a ketogenic diet, for example, seafood, low-carb vegetables, cheese, eggs, meat, poultry, coffee, and tea. The importance of high fat in aging-related sarcopenic obesity reducing regimens on different metabolic models are shown by comparing the effects of four different types of ketogenic dietary regimens [3, 4]. Standard ketogenic diet (SKD): This typically contains a very low, only 5% carbohydrate, 15% moderate proteins, 80% high fat diet. This classic SKD contains a 3:1 ratio to combined protein and carbohydrate. High protein ketogenic diet (HPKD): This contains 5% carbohydrate, 35% protein, and 60% fat. This type is similar to a standard ketogenic diet, but includes more protein [5]. Cyclical ketogenic diet (CKD): This ketogenic diet involves 5 periods of ketogenic days followed by 2 high carbohydrate days [6]. Targeted ketogenic diet (TKD): This ketogenic diet allows you to add carbohydrate around workouts. Although this ketogenic diet is usually safe for weight loss, diabetes, epilepsy, and aging-related sarcopenic obesity, there maybe have some initial side effects while your body adapts [7–9]. Ketogenic diets forces to burn fats rather than carbohydrates. A ketogenic diet, a high fat, in food is converted triglyceride (TG). The liver convers triacylglycerol (TAG) into fatty acid and ketone bodies [10]. Elevated ketone bodies in the blood eventually lowers the aging-related sarcopenic obesity. We hoped to obtain the benefits of ketone dietary therapy that could be maintained indefinitely. Ketone bodies were produced β-hydroxybutyrate, acetoacetate, and acetone by the liver in they consumed a very low-carbohydrate, and excess high-fat diet (Figure 1) [11, 12].
\nKetone bodies. Interrelationships of these three substances. Under certain a high rate of fatty acid oxidation, the liver products collectively of β-hydroxybutyrate, acetoacetate and acetone.
Sarcopenic obesity is caused reduced skeletal muscle mass and strength in order adults. Sarcopenic obesity is most commonly caused by a combination of age and excessive food energy intake, not exercising enough, smoking or heavy alcohol use, although a few caused by genes [13]. Inflammation with aging is known to be a major contributor to sarcopenia [14]. Therefore, sarcopenic obesity has been defined as the loss of skeletal muscle mass and overweight in the older age. As sarcopenic obesity grow older, up to half of the muscle is lost and skeletal muscle is often replaced with fat tissue, particularly in sarcopenic obesity [15]. This is an importance of sarcopenic obesity in the health care for older people. Sarcopenia obesity starts at approximately 40 years of age and there is an estimated muscle mass loss of about 3 ~ 8% per decade, stretching process speeds up until the age of 70 years; after that age, a 15% loss ensues per decade [16]. This group proposed that sarcopenic obesity is diagnosed based on over whole-body weight combination with poor physical functioning [17].
\nThe production of ketone bodies is from the liver. The reverse situation occurs in extrahepatic tissue. Responsible for ketone body formation are associated mainly with the mitochondria. Acetoacetate was formed from the terminal four carbons of a fatty acid upon oxidation. The liver is equipped with the production of acetoacetate from acetoacetyl-CoA (Figure 2). This accounts for the net production of ketone bodies by the liver. Sarcopenic obesity is a newly recognized geriatric syndrome by age-related decline of low skeletal muscle plus a combined approach of overweight body mass that occurs with advancing age [18]. There are several factors contributing to the disorder. Chronic low-grade inflammation has been identified as the initiator in the early stages of many disorders such as physical disability, poor nutrition, and smoking [19, 20]. However, a widely accepted definition of sarcopenic obesity or obese sarcopenia suitable for use in research and clinical practice is still lacking. Sarcopenic obesity is increases the risk of aging-related type 2 diabetes susceptibility to obesity, and it can be the cause of functional dependence and disability in the elderly population [21]. Sarcopenic obesity was significantly associated with greater odds of sarcopenia, overfat, and sarcopenic obesity in women, but not in men [22]. Among older adult sarcopenic obesity characteristics, reduced lean mass at its extreme termed sarcopenia and excess body fatness are predictors of poor health outcomes in the general population. Sarcopenic obesity is at its extreme referred to as ketogenic diet of theorized compound these individual risks [23]. On average, by 20–40% for both men and women in sarcopenic obesity-induced muscles loss and overweight. Overall prevalence of sarcopenia was 26.7% in women and 73.3% in men, which increased with age. Prevalence of obesity was 74.6% in women and 67.1% in men [24]. Thus, defining sarcopenic obesity only in terms of muscle mass is too narrow maybe of limited clinical value that becomes more common in people over the age of 65. Sarcopenic obesity factor seropositivity, and a lack of current treatment with disease-modifying anti-sarcopenic obesity drugs were significantly associated with abnormal body composition such as increasing joint deformity, disability scores and C-reactive protein levels [25]. After middle age, adults lose 3% of their muscle strength every year, on average, to perform many routine activities [26]. These factors contribute to sarcopenic obesity to the characteristic skeletal muscle atrophy and weakness. Sarcopenic obesity also shortens life expectancy in those it affects, compared to individuals with normal muscle strength. Aging-related-sarcopenic obesity is caused by an imbalance between signals for muscle cell growth and signals for teardown [27]. Skeletal muscle cell growth processes are called “muscle anabolism,” and fat cell teardown processes are called “fat catabolism” (Figure 3). Ketogenic diet acts with protein-destroying enzymes to keep muscle steady through a cycle of growth, stress or injury, destruction, and then healing. However, during aging your body becomes resistant to the growth signals, tipping the balance toward catabolism and muscle loss [28].
\nKetogenesis.
The ketone bodies use. Extrahepatic tissues utilize them as respiratory substrates. The ketone bodies from the liver to the extrahepatic tissues coupled with very low activity of enzymes responsible for their utilization. Ketone bodies serve as a fuel for extrahepatic tissues.
The Older women with sarcopenic obesity have an increased all-cause mortality risk independent of obesity [29]. Sarcopenic obesity with obesity and aging, loss of muscle mass as a primary event, and this loss is a major contributor to fat gain, which in turn reinforces the muscle loss. Markedly elevated acetoacetic acid and β-hydroxybutyric acid production in the liver sarcopenic obesity. The various etiologic factors of sarcopenia in aging all lead to loss of muscle [30]. With the increase ketone body in skeletal muscle, acetoacetic acid and β-hydroxybutyric acid secretion are increased, and both lead to sarcopenic obesity resistance, which reduces the fat mass in sarcopenic obesity skeletal muscle and normal anabolic effect of insulin on amino acid transport in muscle [30, 31]. In addition, there is some evidence that acetoacetic acid and β-hydroxybutyric acid reduces fat mass secretion, suppressing another major anabolic stimulus. In addition, higher acetoacetic acid and β-hydroxybutyric acid levels may exert direct catabolic effects on muscle [32] (Figure 4).
\nA ketogenic diet can rebuild skeletal muscle. A ketogenic diet can help you lose fat in the skeletal muscle from sarcopenic obesity. β-hydroxybutyric acid provides the main fuel for moderate and high-intensity exercise.
Sarcopenic obesity in older adults is associated with skeletal poorer performance and strength parameters. Despite β-hydroxybutyric acid in clinical use as a therapy for sarcopenic obesity for several years, the ketogenic diet remains a therapy in search of an explanation [33]. The action of the ketogenic diet is the optimal indications for its clinical use are incompletely defined. We defined the abnormalities in body composition and abdominal fat that occur in sarcopenic obesity is associated with the aging-related presence of skeletal muscle dysfunction. Some features of clinical experience have been replicated in animal models, including the role of ketosis, elevation of triglyceride, total cholesterol, HMG CoA reductase, testosterone. Sarcopenic obesity by both classic ketogenic and β-hydroxybutyric acid diets are better effective at younger ages, and rapid reversal of the sarcopenic obesity effect when the diet is discontinued [34]. Sarcopenic obesity have been implicated in muscle atrophy and dysfunction due to denervation, muscular dystrophy, and disuse. A ketogenic diet plays key roles in sarcopenic obesity in muscle atrophy and the potential of the ketogenic diet for the treatment of sarcopenic obesity in regulating metabolism in skeletal muscle. Several β-hydroxybutyric acid isoforms are potential targets for intervention in sarcopenic obesity. Supplementary of acetoacetic acid and β-hydroxybutyric acid prevents muscle atrophy due to nutrient deprivation [35]. A ketogenic diet regulates metabolism in skeletal muscle and may inhibit oxidative metabolism during aging. Both of acetoacetic acid and β-hydroxybutyric acid have been implicated in muscle atrophy due to skeletal muscle denervation, a process implicated in sarcopenic obesity. Acetoacetic acid or β-hydroxybutyric acid is already in use in the clinic, and there is promise in targeting skeletal muscle for the treatment of sarcopenic obesity [36]. As in the clinical arena, there has been a recent resurgence of interest in pursuing basic questions related to the ketogenic diet. There have been very few animal studies of the ketogenic diet, and those that have been performed are difficult to compare because of wide discrepancies in experimental methods [37]. Earlier models concentrated on the effect of the ketogenic diet on sarcopenic obesity. The effects on the ketogenic diet and satiety, weight loss, and nitrogen balance are discussed as well as influences on electrolytes and the sympathetic system [38]. Hormonal changes of the ketogenic diet regimens and the impact on mood and subjective acceptance are compared. Experimental approaches such as brain metabolic pathways and histological techniques hold much promise in the effort to understand this intriguing alternative to standard ketogenic diet [39]. Though no recommendation for a particular dietary regimen is given, the different implications on the parameters described are pointed out. The global population is aging, the disease is younger and the influence of modern lifestyle, the clinic promotes personalized anti-aging programs, natural nutritional prescriptions, and preventive medical health management to awaken the body’s original anti-aging self-healing power, allowing everyone to reverse the sub-healthy and healthy life, but it does also face the impact of modern diseases. It may be necessary to face the torture of the disease in advance, so the concept of health and advocating naturalness has gradually increased [40].
\nThe ketogenic diet is good for your health. This results in the production of ketones, acetoacetic acid, and β-hydroxybutyric acid. The body uses for acetoacetic acid or β-hydroxybutyric acid to burns body fats, they can lead to weight loss. The possible mechanisms are a decrease in lipogenesis, an increase in lipolysis, and an increase in the metabolic cost of gluconeogenesis. Sarcopenia, obesity and their coexistence, obese sarcopenia, as well as sarcopenic obesity, are among the greatest health concerns in the aging population. A clear age-dependent increased prevalence of sarcopenia and sarcopenic obesity has been registered in the ketogenic diet therapy patients, suggesting mechanistic relationships.
\nInflammation aging is a common ground for age-related sarcopenic obesity. Ketogenic diet therapy is observed greater weight loss compared with other balanced diets. The short-term ketogenic diet is by an almost carbohydrate-free oral diet might have weight loss effectively. Therefore, we suggest the benefits of the ketogenic diet and its risks including supports weight loss, reduce risk of cancers, improve heart health, protect brain function, aging-related sarcopenic obesity, and potentially reduces seizures. In this Chapter, we discuss the aging-related sarcopenic obesity. Nutrition, β-hydroxybutyric acid, in the early development of sarcopenic obesity, cardiomyopathy, dysbiosis and age-associated diseases is our future project. We want to know about sarcopenic obesity during COVID-19 lockdown restrictions. Like many difficult global health problems, the COVID-19 solutions maybe apparent but the logistics of implementing them may be lacking.
\nIn line with the Principles of Transparency and Best Practice in Scholarly Publishing, below is a more detailed description of IntechOpen's Advertising Policy.
",metaTitle:"Advertising Policy",metaDescription:"IntechOpen partners with third-party companies to serve ads and/or collect certain information when you visit our website. These companies may collect non-personally identifiable information (not including your name, address, email address or telephone number) during your visit to IntechOpen's website.",metaKeywords:null,canonicalURL:"/page/advertising-policy",contentRaw:'[{"type":"htmlEditorComponent","content":"1. IntechOpen partners with third-party companies to serve ads and/or collect certain information when you visit our website. These companies may collect non-personally identifiable information (not including your name, address, email address or telephone number) during your visit to IntechOpen's website.
\\n\\n2. All advertisements and commercially sponsored publications are independent from editorial decisions and are linked to reader behaviour.
\\n\\n3. IntechOpen does not endorse any product or service marked as an advertisement on IntechOpen website.
\\n\\n4. IntechOpen has blocked all the inappropriate types of advertising.
\\n\\n5. IntechOpen has blocked advertisement of harmful products or services.
\\n\\n6. Advertisements and editorial content are clearly distinguishable.
\\n\\n7. Editorial decisions will not be influenced by current or potential advertisers and will not be influenced by marketing decisions.
\\n\\n8. Advertisers have no control or influence over the results of searches a user may conduct on the website by keyword or search topic.
\\n\\n9. Please send any complaints about advertising to: info@intechopen.com.
\\n"}]'},components:[{type:"htmlEditorComponent",content:'1. IntechOpen partners with third-party companies to serve ads and/or collect certain information when you visit our website. These companies may collect non-personally identifiable information (not including your name, address, email address or telephone number) during your visit to IntechOpen's website.
\n\n2. All advertisements and commercially sponsored publications are independent from editorial decisions and are linked to reader behaviour.
\n\n3. IntechOpen does not endorse any product or service marked as an advertisement on IntechOpen website.
\n\n4. IntechOpen has blocked all the inappropriate types of advertising.
\n\n5. IntechOpen has blocked advertisement of harmful products or services.
\n\n6. Advertisements and editorial content are clearly distinguishable.
\n\n7. Editorial decisions will not be influenced by current or potential advertisers and will not be influenced by marketing decisions.
\n\n8. Advertisers have no control or influence over the results of searches a user may conduct on the website by keyword or search topic.
\n\n9. Please send any complaints about advertising to: info@intechopen.com.
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5774},{group:"region",caption:"Middle and South America",value:2,count:5239},{group:"region",caption:"Africa",value:3,count:1721},{group:"region",caption:"Asia",value:4,count:10411},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15810}],offset:12,limit:12,total:118377},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"0",sort:"dateEndThirdStepPublish",topicId:"12"},books:[{type:"book",id:"10765",title:"Environmental Management",subtitle:null,isOpenForSubmission:!0,hash:"e5ba02fedd7c87f0ab66414f3b07de0c",slug:null,bookSignature:"Dr. John P. Tiefenbacher",coverURL:"https://cdn.intechopen.com/books/images_new/10765.jpg",editedByType:null,editors:[{id:"73876",title:"Dr.",name:"John P.",surname:"Tiefenbacher",slug:"john-p.-tiefenbacher",fullName:"John P. Tiefenbacher"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10763",title:"Biodiversity of Ecosystems",subtitle:null,isOpenForSubmission:!0,hash:"c96b42d4539957c58dfc2eb8fd9ffc21",slug:null,bookSignature:"Dr. Levente Hufnagel",coverURL:"https://cdn.intechopen.com/books/images_new/10763.jpg",editedByType:null,editors:[{id:"10864",title:"Dr.",name:"Levente",surname:"Hufnagel",slug:"levente-hufnagel",fullName:"Levente Hufnagel"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:18},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:5},{group:"topic",caption:"Business, Management and Economics",value:7,count:2},{group:"topic",caption:"Chemistry",value:8,count:8},{group:"topic",caption:"Computer and Information Science",value:9,count:6},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:7},{group:"topic",caption:"Engineering",value:11,count:20},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:4},{group:"topic",caption:"Materials Science",value:14,count:5},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:25},{group:"topic",caption:"Neuroscience",value:18,count:2},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:3},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:1},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:1}],offset:12,limit:12,total:2},popularBooks:{featuredBooks:[{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5249},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editedByType:"Edited by",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editedByType:"Edited by",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editedByType:"Edited by",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editedByType:"Edited by",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9669",title:"Recent Advances in Rice Research",subtitle:null,isOpenForSubmission:!1,hash:"12b06cc73e89af1e104399321cc16a75",slug:"recent-advances-in-rice-research",bookSignature:"Mahmood-ur- Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9669.jpg",editedByType:"Edited by",editors:[{id:"185476",title:"Dr.",name:"Mahmood-Ur-",middleName:null,surname:"Rahman Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-Ur- Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editedByType:"Edited by",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"1037",title:"Immunogenetics",slug:"immunogenetics",parent:{title:"Immunology, Allergology and Rheumatology",slug:"immunology-allergology-and-rheumatology"},numberOfBooks:3,numberOfAuthorsAndEditors:80,numberOfWosCitations:21,numberOfCrossrefCitations:15,numberOfDimensionsCitations:33,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"immunogenetics",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"7475",title:"Immunogenetics",subtitle:null,isOpenForSubmission:!1,hash:"dd50ca8b9158dc45b6b23fcae43d1daa",slug:"immunogenetics",bookSignature:"Nima Rezaei",coverURL:"https://cdn.intechopen.com/books/images_new/7475.jpg",editedByType:"Edited by",editors:[{id:"116250",title:"Dr.",name:"Nima",middleName:null,surname:"Rezaei",slug:"nima-rezaei",fullName:"Nima Rezaei"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3207",title:"Genes and Autoimmunity",subtitle:"Intracellular Signaling and Microbiome Contribution",isOpenForSubmission:!1,hash:"a3f99e5e0aaeb582b7c17c19982015f7",slug:"genes-and-autoimmunity-intracellular-signaling-and-microbiome-contribution",bookSignature:"Spaska Angelova Stanilova",coverURL:"https://cdn.intechopen.com/books/images_new/3207.jpg",editedByType:"Edited by",editors:[{id:"69749",title:"Prof.",name:"Spaska",middleName:null,surname:"Stanilova",slug:"spaska-stanilova",fullName:"Spaska Stanilova"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2517",title:"Autoimmune Diseases",subtitle:"Contributing Factors, Specific Cases of Autoimmune Diseases, and Stem Cell and Other Therapies",isOpenForSubmission:!1,hash:"a212e9ae7688cbe123bfb1936b3e3cd4",slug:"autoimmune-diseases-contributing-factors-specific-cases-of-autoimmune-diseases-and-stem-cell-and-other-therapies",bookSignature:"James Chan",coverURL:"https://cdn.intechopen.com/books/images_new/2517.jpg",editedByType:"Edited by",editors:[{id:"135686",title:"Dr.",name:"James",middleName:null,surname:"Chan",slug:"james-chan",fullName:"James Chan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:3,mostCitedChapters:[{id:"43379",doi:"10.5772/53440",title:"Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Parallels with Autoimmune Disorders",slug:"chronic-fatigue-syndrome-myalgic-encephalomyelitis-and-parallels-with-autoimmune-disorders",totalDownloads:2022,totalCrossrefCites:2,totalDimensionsCites:4,book:{slug:"genes-and-autoimmunity-intracellular-signaling-and-microbiome-contribution",title:"Genes and Autoimmunity",fullTitle:"Genes and Autoimmunity - Intracellular Signaling and Microbiome Contribution"},signatures:"Ekua W. Brenu, Lotti Tajouri, Kevin J. Ashton, Donald R. Staines and Sonya M. Marshall-Gradisnik",authors:[{id:"41142",title:"Ms",name:"Ekua",middleName:"Weba",surname:"Brenu",slug:"ekua-brenu",fullName:"Ekua Brenu"},{id:"53185",title:"Prof.",name:"Lotti",middleName:null,surname:"Tajouri",slug:"lotti-tajouri",fullName:"Lotti Tajouri"},{id:"53186",title:"Prof.",name:"Sonya",middleName:null,surname:"Marshall-Gradisnik",slug:"sonya-marshall-gradisnik",fullName:"Sonya Marshall-Gradisnik"},{id:"53187",title:"Prof.",name:"Don",middleName:null,surname:"Staines",slug:"don-staines",fullName:"Don Staines"},{id:"125692",title:"Dr.",name:"Kevin",middleName:null,surname:"Ashton",slug:"kevin-ashton",fullName:"Kevin Ashton"}]},{id:"43387",doi:"10.5772/54218",title:"Biomarkers of Inflammatory Arthritis and Proteomics",slug:"biomarkers-of-inflammatory-arthritis-and-proteomics",totalDownloads:2296,totalCrossrefCites:0,totalDimensionsCites:4,book:{slug:"genes-and-autoimmunity-intracellular-signaling-and-microbiome-contribution",title:"Genes and Autoimmunity",fullTitle:"Genes and Autoimmunity - Intracellular Signaling and Microbiome Contribution"},signatures:"Opeyemi S. Ademowo, Lisa Staunton, Oliver FitzGerald and Stephen R. Pennington",authors:[{id:"89766",title:"Prof.",name:"Stephen",middleName:null,surname:"Pennington",slug:"stephen-pennington",fullName:"Stephen Pennington"},{id:"161739",title:"Dr.",name:"Opeyemi Stella",middleName:null,surname:"Ademowo",slug:"opeyemi-stella-ademowo",fullName:"Opeyemi Stella Ademowo"},{id:"161740",title:"Dr.",name:"Oliver",middleName:null,surname:"FitzGerald",slug:"oliver-fitzgerald",fullName:"Oliver FitzGerald"},{id:"167692",title:"Dr.",name:"Lisa",middleName:null,surname:"Staunton",slug:"lisa-staunton",fullName:"Lisa Staunton"}]},{id:"63838",doi:"10.5772/intechopen.80731",title:"Dynamic Interaction between Immune Escape Mechanism and HLA-Ib Regulation",slug:"dynamic-interaction-between-immune-escape-mechanism-and-hla-ib-regulation",totalDownloads:477,totalCrossrefCites:4,totalDimensionsCites:4,book:{slug:"immunogenetics",title:"Immunogenetics",fullTitle:"Immunogenetics"},signatures:"Gia-Gia Toni Ho, Funmilola Heinen, Florian Stieglitz, Rainer Blasczyk and Christina Bade-Döding",authors:[{id:"72037",title:"Prof.",name:"Rainer",middleName:null,surname:"Blasczyk",slug:"rainer-blasczyk",fullName:"Rainer Blasczyk"},{id:"169291",title:"Dr.",name:"Christina",middleName:null,surname:"Bade-Doeding",slug:"christina-bade-doeding",fullName:"Christina Bade-Doeding"},{id:"268556",title:"BSc.",name:"Funmilola",middleName:null,surname:"Heinen",slug:"funmilola-heinen",fullName:"Funmilola Heinen"},{id:"268557",title:"MSc.",name:"Gia-Gia Toni",middleName:null,surname:"Ho",slug:"gia-gia-toni-ho",fullName:"Gia-Gia Toni Ho"},{id:"268558",title:"M.Sc.",name:"Florian",middleName:null,surname:"Stieglitz",slug:"florian-stieglitz",fullName:"Florian Stieglitz"}]}],mostDownloadedChaptersLast30Days:[{id:"66722",title:"Introductory Chapter: Immunogenetics",slug:"introductory-chapter-immunogenetics",totalDownloads:664,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"immunogenetics",title:"Immunogenetics",fullTitle:"Immunogenetics"},signatures:"Amene Saghazadeh and Nima Rezaei",authors:[{id:"116250",title:"Dr.",name:"Nima",middleName:null,surname:"Rezaei",slug:"nima-rezaei",fullName:"Nima Rezaei"},{id:"301367",title:"Dr.",name:"Amene",middleName:null,surname:"Saghazadeh",slug:"amene-saghazadeh",fullName:"Amene Saghazadeh"}]},{id:"60651",title:"Immunoassay Techniques Highlighting Biomarkers in Immunogenetic Diseases",slug:"immunoassay-techniques-highlighting-biomarkers-in-immunogenetic-diseases",totalDownloads:858,totalCrossrefCites:0,totalDimensionsCites:1,book:{slug:"immunogenetics",title:"Immunogenetics",fullTitle:"Immunogenetics"},signatures:"Emilia Manole, Alexandra E. Bastian, Ionela D. Popescu, Carolina Constantin, Simona Mihai, Gisela F. Gaina, Elena Codrici and Monica T. Neagu",authors:[{id:"52215",title:"Prof.",name:"Monica",middleName:null,surname:"Neagu",slug:"monica-neagu",fullName:"Monica Neagu"},{id:"52218",title:"Dr.",name:"Carolina",middleName:null,surname:"Constantin",slug:"carolina-constantin",fullName:"Carolina Constantin"},{id:"89397",title:"Dr.",name:"Emilia",middleName:null,surname:"Manole",slug:"emilia-manole",fullName:"Emilia Manole"},{id:"216223",title:"Dr.",name:"Elena",middleName:null,surname:"Codrici",slug:"elena-codrici",fullName:"Elena Codrici"},{id:"216226",title:"Dr.",name:"Ionela Daniela",middleName:null,surname:"Popescu",slug:"ionela-daniela-popescu",fullName:"Ionela Daniela Popescu"},{id:"216227",title:"Dr.",name:"Simona",middleName:null,surname:"Mihai",slug:"simona-mihai",fullName:"Simona Mihai"},{id:"233495",title:"Dr.",name:"Alexandra",middleName:null,surname:"Bastian",slug:"alexandra-bastian",fullName:"Alexandra Bastian"},{id:"242747",title:"Dr.",name:"Gisela",middleName:null,surname:"Gaina",slug:"gisela-gaina",fullName:"Gisela Gaina"}]},{id:"38028",title:"Immunologic and Genetic Factors in Type 1 Diabetes Mellitus",slug:"immunologic-and-genetic-factors-in-type-1-diabetes-mellitus",totalDownloads:2374,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"autoimmune-diseases-contributing-factors-specific-cases-of-autoimmune-diseases-and-stem-cell-and-other-therapies",title:"Autoimmune Diseases",fullTitle:"Autoimmune Diseases - Contributing Factors, Specific Cases of Autoimmune Diseases, and Stem Cell and Other Therapies"},signatures:"Ahmad Massoud and Amir Hossein Massoud",authors:[{id:"139511",title:"Prof.",name:"Ahmad",middleName:null,surname:"Massoud",slug:"ahmad-massoud",fullName:"Ahmad Massoud"},{id:"141898",title:"Dr.",name:"Amir Hossein",middleName:null,surname:"Massoud",slug:"amir-hossein-massoud",fullName:"Amir Hossein Massoud"}]},{id:"38017",title:"New Therapeutic Challenges in Autoimmune Diseases",slug:"new-therapeutic-challenges-in-autoimmune-diseases",totalDownloads:2704,totalCrossrefCites:0,totalDimensionsCites:4,book:{slug:"autoimmune-diseases-contributing-factors-specific-cases-of-autoimmune-diseases-and-stem-cell-and-other-therapies",title:"Autoimmune Diseases",fullTitle:"Autoimmune Diseases - Contributing Factors, Specific Cases of Autoimmune Diseases, and Stem Cell and Other Therapies"},signatures:"Eun Wha Choi",authors:[{id:"140501",title:"Dr.",name:"Eun Wha",middleName:null,surname:"Choi",slug:"eun-wha-choi",fullName:"Eun Wha Choi"}]},{id:"43369",title:"Microbiome and Autoimmunity",slug:"microbiome-and-autoimmunity",totalDownloads:1365,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"genes-and-autoimmunity-intracellular-signaling-and-microbiome-contribution",title:"Genes and Autoimmunity",fullTitle:"Genes and Autoimmunity - Intracellular Signaling and Microbiome Contribution"},signatures:"Natalie Cherepahina, Zaur Shogenov, Mariya Bocharova, Murat Agirov, Jamilyia Tabaksoeva, Mikhail Paltsev and Sergey Suchkov",authors:[{id:"49135",title:"Dr.",name:"Natalie",middleName:null,surname:"Cherepahina",slug:"natalie-cherepahina",fullName:"Natalie Cherepahina"},{id:"49136",title:"Dr.",name:"Jamiliya",middleName:null,surname:"Tabaksoeva",slug:"jamiliya-tabaksoeva",fullName:"Jamiliya Tabaksoeva"},{id:"49137",title:"Dr.",name:"Murat",middleName:null,surname:"Agirov",slug:"murat-agirov",fullName:"Murat Agirov"},{id:"155909",title:"Prof.",name:"Sergey",middleName:null,surname:"Suchkov",slug:"sergey-suchkov",fullName:"Sergey Suchkov"},{id:"158987",title:"BSc.",name:"Mariya",middleName:null,surname:"Bocharova",slug:"mariya-bocharova",fullName:"Mariya Bocharova"},{id:"160426",title:"Dr.",name:"Zaur",middleName:null,surname:"Shogenov",slug:"zaur-shogenov",fullName:"Zaur Shogenov"},{id:"160429",title:"Prof.",name:"Mikhail",middleName:null,surname:"Paltsev",slug:"mikhail-paltsev",fullName:"Mikhail Paltsev"}]},{id:"43387",title:"Biomarkers of Inflammatory Arthritis and Proteomics",slug:"biomarkers-of-inflammatory-arthritis-and-proteomics",totalDownloads:2299,totalCrossrefCites:0,totalDimensionsCites:4,book:{slug:"genes-and-autoimmunity-intracellular-signaling-and-microbiome-contribution",title:"Genes and Autoimmunity",fullTitle:"Genes and Autoimmunity - Intracellular Signaling and Microbiome Contribution"},signatures:"Opeyemi S. Ademowo, Lisa Staunton, Oliver FitzGerald and Stephen R. Pennington",authors:[{id:"89766",title:"Prof.",name:"Stephen",middleName:null,surname:"Pennington",slug:"stephen-pennington",fullName:"Stephen Pennington"},{id:"161739",title:"Dr.",name:"Opeyemi Stella",middleName:null,surname:"Ademowo",slug:"opeyemi-stella-ademowo",fullName:"Opeyemi Stella Ademowo"},{id:"161740",title:"Dr.",name:"Oliver",middleName:null,surname:"FitzGerald",slug:"oliver-fitzgerald",fullName:"Oliver FitzGerald"},{id:"167692",title:"Dr.",name:"Lisa",middleName:null,surname:"Staunton",slug:"lisa-staunton",fullName:"Lisa Staunton"}]},{id:"42187",title:"Common Mechanisms of Pathogenesis of Tissue-Specific Autoimmune Diseases: The Edited Model to Illustrate Those for IDDM and Multiple Sclerosis",slug:"common-mechanisms-of-pathogenesis-of-tissue-specific-autoimmune-diseases-the-edited-model-to-illustr",totalDownloads:1159,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"genes-and-autoimmunity-intracellular-signaling-and-microbiome-contribution",title:"Genes and Autoimmunity",fullTitle:"Genes and Autoimmunity - Intracellular Signaling and Microbiome Contribution"},signatures:"S. A. Krynskiy, A. V. Kostyakov, D. S. Kostyushev, D. A. Gnatenko and S. V. Suchkov",authors:[{id:"155909",title:"Prof.",name:"Sergey",middleName:null,surname:"Suchkov",slug:"sergey-suchkov",fullName:"Sergey Suchkov"},{id:"49152",title:"Dr.",name:"Dmitry",middleName:"Sergeevich",surname:"Kostyushev",slug:"dmitry-kostyushev",fullName:"Dmitry Kostyushev"},{id:"107360",title:"Prof.",name:"Dmitrii",middleName:null,surname:"Gnatenko",slug:"dmitrii-gnatenko",fullName:"Dmitrii Gnatenko"},{id:"160848",title:"Dr.",name:"Sergey",middleName:null,surname:"Krynskiy",slug:"sergey-krynskiy",fullName:"Sergey Krynskiy"},{id:"160854",title:"Dr.",name:"Artem",middleName:null,surname:"Kostyakov",slug:"artem-kostyakov",fullName:"Artem Kostyakov"}]},{id:"43377",title:"Environmental Factors and Type 1 Diabetes Mellitus in Pediatric Age Group",slug:"environmental-factors-and-type-1-diabetes-mellitus-in-pediatric-age-group",totalDownloads:1358,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"genes-and-autoimmunity-intracellular-signaling-and-microbiome-contribution",title:"Genes and Autoimmunity",fullTitle:"Genes and Autoimmunity - Intracellular Signaling and Microbiome Contribution"},signatures:"Giuseppe d'Annunzio, Andrea Accogli, Ramona Tallone, Sara Bolloli and Renata Lorini",authors:[{id:"39758",title:"Dr.",name:"Giuseppe",middleName:null,surname:"D'Annunzio",slug:"giuseppe-d'annunzio",fullName:"Giuseppe D'Annunzio"},{id:"52572",title:"Prof.",name:"Renata",middleName:null,surname:"Lorini",slug:"renata-lorini",fullName:"Renata Lorini"},{id:"53744",title:"Dr.",name:"Ramona",middleName:null,surname:"Tallone",slug:"ramona-tallone",fullName:"Ramona Tallone"},{id:"166311",title:"Dr.",name:"Andrea",middleName:null,surname:"Accogli",slug:"andrea-accogli",fullName:"Andrea Accogli"},{id:"166312",title:"Dr.",name:"Sara",middleName:null,surname:"Bolloli",slug:"sara-bolloli",fullName:"Sara Bolloli"}]},{id:"43367",title:"Immune Synapses Between Lymphocytes and Target Cells in Autoimmune Thyroid Diseases",slug:"immune-synapses-between-lymphocytes-and-target-cells-in-autoimmune-thyroid-diseases",totalDownloads:1426,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"genes-and-autoimmunity-intracellular-signaling-and-microbiome-contribution",title:"Genes and Autoimmunity",fullTitle:"Genes and Autoimmunity - Intracellular Signaling and Microbiome Contribution"},signatures:"Iwona Ben-Skowronek and Roman Ciechanek",authors:[{id:"37123",title:"Dr",name:"Iwona",middleName:null,surname:"Ben-Skowronek",slug:"iwona-ben-skowronek",fullName:"Iwona Ben-Skowronek"}]},{id:"43549",title:"Toll-Like Receptor 3 and Retinoic Acid-Inducible Gene-I Implicated to the Pathogenesis of Autoimmune Renal Diseases",slug:"toll-like-receptor-3-and-retinoic-acid-inducible-gene-i-implicated-to-the-pathogenesis-of-autoimmune",totalDownloads:1124,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"genes-and-autoimmunity-intracellular-signaling-and-microbiome-contribution",title:"Genes and Autoimmunity",fullTitle:"Genes and Autoimmunity - Intracellular Signaling and Microbiome Contribution"},signatures:"Hiroshi Tanaka and Tadaatsu Imaizumi",authors:[{id:"37530",title:"Dr.",name:"Hiroshi",middleName:null,surname:"Tanaka",slug:"hiroshi-tanaka",fullName:"Hiroshi Tanaka"}]}],onlineFirstChaptersFilter:{topicSlug:"immunogenetics",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"chapter.detail",path:"/books/advances-in-international-rice-research/the-application-of-genomic-approaches-in-studying-a-bacterial-blight-resistant-mutant-in-rice",hash:"",query:{},params:{book:"advances-in-international-rice-research",chapter:"the-application-of-genomic-approaches-in-studying-a-bacterial-blight-resistant-mutant-in-rice"},fullPath:"/books/advances-in-international-rice-research/the-application-of-genomic-approaches-in-studying-a-bacterial-blight-resistant-mutant-in-rice",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()